Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aveo Eyes Role For Tivozanib In US Kidney Cancer Market, Against The Odds

Nov 07 2018

• By Emily Hayes

Human kidney on scientific background. 3d illustration

Related Content

Pfizer Well-Placed To Lead First-Line Advanced RCC Market

Oct 30 2018

Novartis Terminates Development Of Aveo Antibody

Jul 04 2018

Immuno-Oncology Outlook: Pfizer's Inlyta Fits Well In Combos For Kidney Cancer

Jun 29 2017

Aveo’s Tivozanib Troubles Reflect Perils Of Ex-U.S. Studies

May 06 2013

Aveo’s Tivozanib Falls On Survival Data, Study Design Flaws

May 02 2013

Related Companies

AVEO Pharmaceuticals, Inc.

Kyowa Kirin Co., Ltd.

Bristol Myers Squibb Company

Pfizer Inc.

Merck & Co., Inc.

Additional Topics

Research & Development Cancer BioPharmaceutical

More from Anticancer

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window